These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 970124)

  • 21. Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder.
    Kakizoe T; Tobisu K; Takai K; Tanaka Y; Kishi K; Teshima S
    Cancer Res; 1988 Apr; 48(8):2299-303. PubMed ID: 3349494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing the survival of patients with transitional cell tumours of the urinary bladder.
    Pryor JP
    Br J Urol; 1973 Dec; 45(6):586-92. PubMed ID: 4775737
    [No Abstract]   [Full Text] [Related]  

  • 23. Factors affecting recurrence and progression in superficial bladder tumours.
    Kurth KH; Denis L; Bouffioux C; Sylvester R; Debruyne FM; Pavone-Macaluso M; Oosterlinck W
    Eur J Cancer; 1995 Oct; 31A(11):1840-6. PubMed ID: 8541110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder.
    Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Navone R
    Am J Surg Pathol; 2001 Dec; 25(12):1528-33. PubMed ID: 11717543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early lesions and natural progression of bladder carcinoma (minute bladder carcinoma).
    Kishi K; Kakizoe T; Tobisu K; Tanaka Y; Niizuma M
    Jpn J Clin Oncol; 1989 Mar; 19(1):3-13. PubMed ID: 2921815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inverted papillary carcinoma].
    Angulo JC; López JI; Toledo JD; Flores Corral N
    Arch Esp Urol; 1993 Oct; 46(8):695-8. PubMed ID: 8311519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.
    Raitanen MP; Nieminen P; Tammela TL
    Br J Urol; 1995 Oct; 76(4):470-4. PubMed ID: 7551884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
    J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histoprognostic evaluation of papillary bladder tumors.
    Piazza M; Dalla Palma P; Gentile HM
    Urology; 1980 Aug; 16(2):207-11. PubMed ID: 7404924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does muscularis mucosae invasion in extensively lamina propria-invasive high-grade papillary urothelial carcinoma provide additional prognostic information?
    Pan CC
    Am J Surg Pathol; 2013 Mar; 37(3):459-60. PubMed ID: 23388127
    [No Abstract]   [Full Text] [Related]  

  • 33. The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.
    Angulo JC; Lopez JI; Flores N; Toledo JD
    J Cancer Res Clin Oncol; 1993; 119(10):578-93. PubMed ID: 8335677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course.
    Takashi M; Sakata T; Murase T; Hamajima N; Miyake K
    Nagoya J Med Sci; 1991 Mar; 53(1-4):1-8. PubMed ID: 1805133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
    Lawless M; Gulati R; Tretiakova M
    Histopathology; 2017 Sep; 71(3):406-414. PubMed ID: 28470753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years.
    Larsson P; Wijkström H; Thorstenson A; Adolfsson J; Norming U; Wiklund P; Onelöv E; Steineck G
    Scand J Urol Nephrol; 2003; 37(3):195-201. PubMed ID: 12775276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats.
    Kunze E; Schauer A; Schatt S
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976; 87(2):139-60. PubMed ID: 136822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of pS2 protein in transitional cell bladder tumours.
    Lipponen PK; Eskelinen MJ
    J Pathol; 1994 Aug; 173(4):327-32. PubMed ID: 7965392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urothelial papilloma of the bladder: a review of 34 de novo cases.
    Magi-Galluzzi C; Epstein JI
    Am J Surg Pathol; 2004 Dec; 28(12):1615-20. PubMed ID: 15577681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.